Solid Biosciences
SLDB
SLDB
149 hedge funds and large institutions have $717M invested in Solid Biosciences in 2026 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 55 increasing their positions, 40 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
16% more funds holding
Funds holding: 129 → 149 (+20)
3.11% less ownership
Funds ownership: 104.45% → 101.34% (-3.1%)
Holders
149
Holding in Top 10
4
Calls
$2.2M
Puts
$1.12M
Top Buyers
| 1 | +$25.8M | |
| 2 | +$22.9M | |
| 3 | +$22.7M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$15.7M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$12.2M |
Top Sellers
| 1 | -$5.42M | |
| 2 | -$5.24M | |
| 3 | -$5.22M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$2.82M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.35M |
